Department of Genetics and Applied Microbiology, Faculty of Science and Technology, University of Debrecen, Debrecen, Egyetem tér 1, 4032, Hungary.
BMC Microbiol. 2020 Oct 21;20(1):320. doi: 10.1186/s12866-020-01942-0.
Pathogenic fungi often cause serious infections mainly in immunocompromised persons. The number of infections caused by the non-albicans Candida or other species has significantly increased over the last years. These infections present a major challenge in the health sector because these pathogenic fungi have strong virulence and often show resistance to the commonly used antifungal treatments. To solve the problems caused by the drug resistant pathogenic fungi, it is necessary to find new antifungal agents and their sources. The aim of this study was to give evidence that yeasts can effectively fight against strains which belong to pathogenic fungi and reveal those yeasts which are able to inhibit growth of Kodamaea ohmeri, Pichia kudriavzevii, Naganishia albida or Candida tropicalis. Furthermore, we wanted to determine the effects of certain culturing factors on the growth inhibition.
Our screening revealed that although the strains belonging to pathogenic species were much more tolerant to the yeast-produced bioactive agents than the non-disease-associated yeasts, growth of Kodamaea ohmeri and Candida tropicalis could be inhibited by Metschnikowia andauensis, while Naganishia albida could be controlled by Pichia anomala or Candida tropicalis. Our data proved that the experimental circumstances could have a serious impact on the inhibitory capacity of the yeasts. Appearance of inhibition strongly depended on media, pH and temperature. Our data also shed some light on the fact that Pichia kudriavzevii must have high natural resistance to the yeast-produced agents, while other species, such as Saccharomycopsis crataegensis belonged to the easily inhibitable species.
Our study suggests that yeast-produced bioactive agents could be potential growth inhibitory agents against the disease-associated fungi and yeasts can also contribute to alternative approaches to combat against pathogenic fungi. Our data revealed an important role of the culturing factors in inhibition and pointed to the complex nature of antagonism.
致病性真菌常导致免疫功能低下人群发生严重感染。近年来,非白色念珠菌或其他物种引起的感染数量显著增加。这些感染对卫生部门构成了重大挑战,因为这些致病性真菌具有很强的毒力,而且往往对常用的抗真菌治疗具有耐药性。为了解决耐药性致病真菌引起的问题,有必要寻找新的抗真菌药物及其来源。本研究旨在证明酵母能有效对抗属于致病性真菌的菌株,并揭示那些能抑制 Kodamaea ohmeri、Pichia kudriavzevii、Naganishia albida 或 Candida tropicalis 生长的酵母。此外,我们还想确定某些培养因素对生长抑制的影响。
我们的筛选结果表明,虽然属于致病性种的菌株比非疾病相关酵母对酵母产生的生物活性物质的耐受性更强,但 Metschnikowia 和auensis 可以抑制 Kodamaea ohmeri 和 Candida tropicalis 的生长,而 Pichia anomala 或 Candida tropicalis 可以控制 Naganishia albida 的生长。我们的数据证明,实验条件会对酵母的抑制能力产生严重影响。抑制的出现强烈依赖于培养基、pH 值和温度。我们的数据还表明,Pichia kudriavzevii 必须对酵母产生的物质具有高天然抗性,而其他物种,如 Saccharomycopsis crataegensis 则属于易受抑制的物种。
我们的研究表明,酵母产生的生物活性物质可能是对抗疾病相关真菌的潜在生长抑制剂,酵母也可以为对抗致病性真菌提供替代方法。我们的数据揭示了培养因素在抑制中的重要作用,并指出了拮抗作用的复杂性。